(Q79452041)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17189989%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

title

Protocol modifications influence the result of EGF receptor immunodetection by EGFR pharmDx in paraffin-embedded cancer tissues (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17189989%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

author name string

Katalin Derecskei

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17189989%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Judit Moldvay

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17189989%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Krisztina Bogos

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17189989%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

József Tímár

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17189989%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

publication date

25 December 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17189989%20AND%20SRC:MED&resulttype=core&format=json

Pathology Oncology Research

23 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17189989%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17189989%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17189989%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

page(s)

243-246

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17189989%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf02893421

23 December 2019

exact match

0 references

cites work

Phase I/IIa study of cetuximab with gemcitabine plus carboplatin in patients with chemotherapy-naive advanced non-small-cell lung cancer

1 reference

12 December 2020

Biological markers for non-small cell lung cancer patient selection for epidermal growth factor receptor tyrosine kinase inhibitor therapy

1 reference

12 December 2020

Epidermal growth factor receptor inhibitors in colorectal cancer: it's time to get back on target

1 reference

12 December 2020

Expression of epidermal growth factor receptor in invasive transitional cell carcinoma of the urinary bladder. A multivariate survival analysis

1 reference

12 December 2020

Searching for reliable epidermal growth factor receptor response predictors: commentary re M. K. Nyati et al., Radiosensitization by pan-ErbB inhibitor CI-1033 in vitro and in vivo. Clin. Cancer Res., 10: 691-700, 2004.

1 reference

12 December 2020

Critical update and emerging trends in epidermal growth factor receptor targeting in cancer

1 reference

12 December 2020

Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry.

1 reference

12 December 2020

Phase II Multicenter Study of the Antiepidermal Growth Factor Receptor Monoclonal Antibody Cetuximab in Combination With Platinum-Based Chemotherapy in Patients With Platinum-Refractory Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head

1 reference

12 December 2020

Predictive factors for epidermal growth factor receptor inhibitors--the bull's-eye hits the arrow

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02893421

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17189989%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

1 reference